KROS Dividend History & Analysis | N/A Yield
KROS has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| ABBV | 398,492 M | 3.34% | 9.78% |
| QIA | 8,543 M | 5.34% | 5.59% |
| GILD | 180,267 M | 3.36% | 6.0% |
| AMGN | 197,412 M | 3.07% | 5.83% |
| NOV | 170,550 M | 2.81% | 5.69% |
| Symbol | Market Cap USD | Growth Rate | Consistency |
|---|---|---|---|
| BTX | 727 M | 134% | 95.6% |
| HLN | 44,673 M | 30.1% | 100% |
| BIM | 12,852 M | 9.76% | 96.0% |
| AMGN | 197,412 M | 7.84% | 100% |
| ABBV | 398,492 M | 5.98% | 100% |
Quality Dividend Peers in Biotechnology
3.07% Yield
3.36% Yield
KROS Dividend History: as of March 2026
No dividends paid yet.KROS Dividend FAQ
Keros Therapeutics, Inc. (NASDAQ: KROS) is a clinical-stage biopharma focused on novel therapies that modulate the transforming growth factor-beta (TGF-β) signaling pathway. Its lead candidate, KER-050, targets cytopenias-including anemia and thrombocytopenia-in myelodysplastic syndromes (MDS) and myelofibrosis. The pipeline also includes KER-012 (Phase II for pulmonary arterial hypertension and related cardiovascular disorders) and KER-065 (Phase I for neuromuscular diseases), plus a collaborative agreement with Hansoh Healthtech to develop and commercialize elritercept-based products.
What is the Dividend Yield of KROS?
As of March 2026, KROS`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 11.03.Does KROS pay a dividend?
As of March 2026 KROS does not pay a dividend.How often does KROS pay dividends?
Over the last 12 months, KROS has issued dividend payments.KROS dividend forecast
Based on historical data, the forecasted dividends per share for KROS for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).This suggests the dividend will remain relatively stable.
Will KROS pay dividends in 2026?
The next Ex-Dividend date for Keros Therapeutics (KROS) is currently unknown.What is the next Ex-Dividend Date for KROS?
The next Ex-Dividend date for Keros Therapeutics (KROS) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of KROS?
KROS's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of KROS?
KROS's 5-Year Yield on Cost is -%. If you bought KROS's shares at 55.00 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of KROS?
KROS Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does KROS have a good Dividend Yield?
KROS`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of KROS?
The Dividend Payout Ratio of KROS is unknown.What is the Dividend Rating of KROS?
KROS`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield
- Annual dividend per share divided by current share price.
- Payout Ratio
- Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
- Payout FCF
- Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
- Growth Rate (CAGR)
- Compound annual growth rate of dividends over the last 5 years.
- Consistency
- Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
- Yield on Cost
- Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
- Streak
- Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
- Dividend Rating
- Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-03-08 02:15